This ServiceNow Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday
This ServiceNow Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday
這位ServiceNow分析師以看好的態度開始覆蓋;以下是週二的三大啓動對象
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
頂級華爾街分析師改變了他們對這些頂級股票的看法。有關所有分析師評級變動的完整信息,包括評級上調和下調,請查看我們的分析師評級頁面。
- Raymond James analyst Robert Majek initiated coverage on ServiceNow, Inc. (NYSE:NOW) with an Outperform rating and announced a price target of $1200. ServiceNow shares closed at $1,088.26 on Monday. See how other analysts view this stock.
- D. Boral Capital analyst Jason Kolbert initiated coverage on AVITA Medical, Inc. (NASDAQ:RCEL) with a Buy rating and announced a price target of $25. AVITA Medical shares closed at $11.75 on Monday. See how other analysts view this stock.
- LifeSci Capital analyst Cory Jubinville initiated coverage on Mereo BioPharma Group (NASDAQ:MREO) with an Outperform rating and announced a price target of $10. Mereo BioPharma shares closed at $3.39 on Monday. See how other analysts view this stock.
- 雷蒙德·詹姆斯分析師羅伯特·馬傑克對ServiceNow, Inc.(紐交所:NOW)進行了覆蓋,給出了優於大盤的評級,並宣佈目標價爲1200美元。ServiceNow的股票在星期一收盤價爲1088.26美元。看看其他分析師對這隻股票的看法。
- D. Boral Capital分析師傑森·科爾伯特對Avita Medical, Inc.(納斯達克:RCEL)進行了覆蓋,給予買入評級,並宣佈目標價爲25美元。Avita Medical的股票在星期一收盤價爲11.75美元。看看其他分析師對這隻股票的看法。
- LifeSci Capital分析師科裏·朱賓維爾對Mereo BioPharma Group(納斯達克:MREO)進行了覆蓋,給出了優於大盤的評級,並宣佈目標價爲10美元。Mereo BioPharma的股票在星期一收盤價爲3.39美元。看看其他分析師對這隻股票的看法。
Considering buying NOW stock? Here's what analysts think:
考慮購買NOW股票嗎?以下是分析師的想法:
Read This Next:
接下來閱讀:
- How To Earn $500 A Month From Qualcomm Stock
- 如何從高通股票中每月賺取500美元